white Home SCGS Therapies & Tecnologies Alternative Sources Steam Cells Careers QA Comments Contact
Events
Conventional  

Conventional therapy can be defined as a group of new techniques, or technologies, that rely on replacing diseased or dysfunctional cells with healthy, functioning ones. Treatment involves a series of intravenous infusions of stem cells derived from embryo, umbilical cord, bone marrow and other sources.

There Are List of Diseases And Disorders Amenable To Stem Cell Therapy Today.

Neurological disorders

Parkinson's disease

Human dopaminergic neurons for PD

Graft survival-enhancing drugs

Xenografting porcine fetal neurons

Encapsulated cells for PD

Stem cells for PD

Stem cells for production of glial derived neurotrophic factor

Potential of regeneration of endogenous stem cells in PD

Human retinal pigment epithelium cells for PD

Coaxing hESCs to produce dopamine

Tumorigenic potential of transplantated dopaminergic hESCs

Delivery of cells for PD

Cell therapy for Huntington's disease

Fetal striatal cell transplantation

Transplantation of encapsulated porcine choroids plexus cells

Cell therapy for Alzheimer's disease

Cell therapy for Amyotrophic Lateral Sclerosis

Cell therapy for Lysosomal Storage Disorders

Cell therapy for Battens disease

Genetically modified HSCs for metachromatic leukodystrophy

Cell therapy for Demyelinating Disorders

Hematopoietic stem cell transplantation for multiple sclerosis

Embryonic stem cells for remyelination

Neural precursor cells for neuroprotection in multiple sclerosis

Stem cell transplantation for chronic inflammatory demyelinating polyneuropathy

Cell therapy of Stroke

Transplantation of encapsulated porcine choroids plexus

Transplantation of fetal porcine cells Neural stem cell therapy for stroke

Intravenous infusion of marrow stromal cells

Intravenous infusion of umbilical cord blood stem cells

Intracerebral administration of human adipose tissue stromal cells

Intracerebral administration of multipotent adult progenitor cells

Cell therapy for Cerebral Palsy

Cell and gene Therapy of Epilepsy

Cell therapy of Traumatic Brain injury

Cell therapy of spinal cord injuries

Transplantation of glial cells for SCI

Fetal neural grafts for SCI

Embryonic stem cells for SCI

Oligodendrocyte precursor cells for treatment of SCI

Schwann cell transplants for SCI

Olfactory-ensheathing cells for SCI

Autologous bone marrow cell transplantation for SCI

Marrow stromal cells for SCI

Intravenous injection of stem cells for spinal cord repair Combined cell/gene therapy for SCI

Delivery of cells in SCI

Cell therapy of Syringomyelia

Cell transplants for Peripheral nerve injuries

Umbilical cord blood stem cells for neurogenetic disorders

UCB stem cells for Krabbes disease

UCB stem cells for Hurler's syndrome

UCB stem cells for Sanfilippo syndrome type B

Cell therapy for developmental neurological disorders

Cell therapy for cerebral palsy

Cell therapy for muscular dystrophy

Cell transplant for Duchenne muscular dystrophy

Myoblast-based gene transfer

Improvement of DMD therapy by using muscle-derived stem cells

Hematopoietic stem cells for DMD

Cell therapy for retinal degenerative disorders

Genetically engineered retinal pigmented epithelial cell lines

Delivery of CNTF by encapsulated cell intraocular implants

Stem cell transplantation in the retina

Human retinal stem cells

Isolation of RPE cells from hESCs using transcriptomics

ESCs for retinal degenerative disorders

Combining cell and gene therapies for retinal disorders

Stem cell therapy for hearing loss

Cell therapy for hematological disorders

Ex vivo cell/gene therapy of hemophilia B

. Ex vivo cell/gene therapy of hemophilia A

Hematopoietic stem cell therapy for thrombocytopenia

Stem cell transplant for sickle cell anemia

Modified hematopoietic stem cells for chronic acquired anemias

Transplantation of autologous hematopoietic stem cells

Stem cell therapy of hemoglobinopathies

Cell therapy for immunological disorders

Modifying immune responses of DCs by vaccination with lipiodol-siRNA mixtures

Stem cell therapy of chronic granulomatous disease

Stem cell therapy of X-linked severe combined immunodeficiency

Stem cell therapy of autoimmune disorders

Treatment of Crohn's disease with stem cells

Treatment of rheumatoid arthritis with stem cells

Stem cell transplants for scleroderma

Autologous T-cells from adult stem cells

Cell therapy for diabetes mellitus

Islet cell transplantation

Autologous pancreatic islet cell transplantation in chronic pancreatitis

Monitoring of islet cell transplants with MRI

Encapsulated porcine pancreatic islet cells for pancreas

Encapsulated insulinoma cells

Islet precursor cells Xenotransplantation of embryonic pancreatic tissue

Non-pancreatic tissues for generation of insulin-producing cells

Bio-artificial substitutes for pancreas

Stem cell injection into portal vein of diabetic patients

Dendritic cell-based therapy for type 1 diabetes

Gene therapy in diabetes

Genetically engineered dendritic cells

Genetically altered liver cells

Genetically modified stem cells

Cell therapy for liver disorders

Bioartificial liver

Stem cells for hepatic disorders

Cell-based gene therapy for liver disorders

Transplantation of genetically modified fibroblasts

Transplantation of genetically modified hepatocytes

Intraperitoneal hepatocyte transplantation

Genetically modified hematopoietic stem cells

Cell therapy of renal disorders

Bioartificial kidney

Bone marrow stem cells for renal disease

Human stem cells to prevent end stage renal disease

Mesangial cell therapy

Cell therapy for pulmonary disorders

Cell therapy for cystic fibrosis

Lung tissue regeneration from stem cells

Differentiation of UCBs into respiratory epithelial cells

Cell therapy for disorders of bones and joints

Repair of fractures and bone defects

Adult stem cells for bone grafting

Stem cells for repairing skull defects

Mesenchymal stem cells for repair of bones and joints

Intrauterine use of MSCs for osteogenesis imperfecta In vivo bone engineering as an alternative to cell transplantation Mosaicplasty

Autologous cultured chondrocytes

Autologous intervertebral disc chondrocyte transplantation

Cartilage repair by genetically modified fibroblasts expressing TGF -?

Generation of cartilage from stem cells

Platelet injection for tennis elbow

Cell therapy of rheumatoid arthritis

Wound healing: skin and soft tissue repair

Cell therapy for burns

Cells to form skin substitutes for healing ulcers

Cell therapy for wound repair

Genetically engineered cells for wound repair

Cell therapy for corneal repair

Closure of incisions with laser guns and cells

Repair of aging skin by injecting autologous fibroblasts

Role of cells in tissue engineering and reconstructive surgery

Scaffolds for tissue engineering

Choosing cells for tissue engineering

ESCs vs adult SCs for tissue engineering

Engineering of healthy living teeth from stem cells

Adipose tissue-derived stem cells for breast reconstruction

Generation of complex organs from adult stem cells

Strategies to improve stem cell transplantation for tissue engineering

Use of adult MSCs for tissue engineering

Improving tissue engineering of bone by MSCs

Intra-uterine repair of congenital defects using amniotic fluid MSCs .

Cell-based tissue engineering in genitourinary system

Urinary incontinence

Tissue engineering of urinary bladder

Repair of the pelvic floor with stem cells from the uterus

Cell Therapy for Cardiovascular Disorders

Transplantation of myoblasts for myocardial infarction

Cellular cardiomyoplasty

IGF-1 delivery by nanofibers to improve cell therapy for MI

Pravastatin for expansion of endogenous progenitor and stem cells

Transplantation of stem cells for myocardial infarction

Transplantation of cord blood stem cells

Transplantation of hESCsTransplantation of HSCs

Transplantation of autologous angiogenic cell precursors

Regeneration of the chronic myocardial infarcts by HSC therapy

Transplantation of adipose-derived stem cells

Intracoronary infusion of bone marrow-derived cells for AMI

Intracoronary infusion of mobilized peripheral blood stem cells

Human mesenchymal stem cells for cardiac regeneration

Cytokine preconditioning of human fetal liver CD133+ SCs

Transplantation of expanded adult SCs derived from the heart

Transplantation of endothelial cells

Transplantation of cardiomyocytes differentiated from hESCs

Simultaneous transplantation of autologous MSCs and skeletal myoblasts

MSCs for hibernating myocardium

Transplantation of cells secreting vascular endothelial growth factor

Transplantation of genetically modified bone marrow stem cells

Myoblasts for treatment of congestive heart failure

Injection of adult stem cells for congestive heart failure

AngioCell gene therapy for congestive heart failure

Atrioventricular conduction block

Ventricular tachycardia

Prevention of myoblast-induced arrhythmias by genetic engineering

Construction of blood vessels with cells

Fetal cardiomyocytes seeding in tissue-engineered cardiac grafts

UCB progenitor cells for engineering heart valves

SC therapy for cancer

Cellular immunotherapy for cancer

Treatments for cancer by ex vivo mobilization of immune cells

Cancer vaccines

Autologous tumor cell vaccines

Vaccines that simultaneously target different cancer antigens

Gene modified cancer cells vaccines

GVAX cancer vaccines

The use of dendritic cells for cancer vaccination

Basics of dendritic cell vaccines

Preclinical and clinical studies with DC vaccines In vivo manipulation of dendritic cells

Autologous dendritic cells loaded ex vivo with telomerase mRNA

Dendritic/tumor cell fusion

Genetically modified dendritic cells Future developments in DC vaccines

Lymphocyte-based cancer therapies

Adoptive immunotherapy

Rescue of CD8+ T cells for use in tumor immunotherapy

Expansion of antigen-specific cytotoxic T lymphocytes

Xcellerated T Cells

Tumor infiltrating lymphocytes

Genetic engineering of tumor cells

Stem cell-based anticancer therapies

Stem cell transplantation in cancer

Peripheral blood stem cell transplantation

Autologous stem cell transplantation

Complications of stem cell transplants in cancer

Long-term results of HSC transplantation

Prediction of T -cell reconstitution after HSC transplantation.

Mesenchymal stem cell transplantation in cancer

Nonmyeloablative allogeneic hematopoietic stem cell transplantation

Umbilical cord blood transplant for leukemia

hESC-derived NK cells for treatment of cancer

Genetic modification of stem cells

Genetic modification of hematopoietic stem cells

Use of hematopoietic stem cells to deliver suicide genes to tumors

Delivery of anticancer agents by genetically engineered MSCs

Peripheral blood stem cell transplantation

Stem cell transplantation for radiation sickness

Stem cells and human reproduction

Expansion of spermatogonial stem cells

Conversion of ESCs into spermatogonial stem cells

Conversion of stem cells to oocytes

ESCs for treatment of infertility in women

Cloning human embryos from oocytes matured in the laboratory

In utero stem cell transplantation


Join now for more...

  Copyright 2008 Consumer's Guide to Stem Cells. All rights reserved. Terms and Conditions